Jun Guo

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Locally Advanced

Diffusion Weighted

Top Venues

Cancer research communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Dai, Jia Jia, Fanshuang Zhang, Kaihua Liu, Yanfeng Xi, Pei Yuan, Lili Mao, Xue Bai, Xiaoting Wei, Bingning Wang, Jiangtao Li, Yang Xu, Ting Liu, Shuang Chang, Yang W Shao, Jun Guo, Jianming Ying, Lu Si
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications. Cancer research communications (2024)
Jie Dai, Jia Jia, Fanshuang Zhang, Kaihua Liu, Yanfeng Xi, Pei Yuan, Lili Mao, Xue Bai, Xiaoting Wei, Bingning Wang, Jiangtao Li, Yang Xu, Ting Liu, Shuang Chang, Yang W Shao, Jun Guo, Jianming Ying, Lu Si
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications. Cancer research communications 4 (5) (2024)
Jie Dai, Jia Jia, Fanshuang Zhang, Kaihua Liu, Yanfeng Xi, Pei Yuan, Lili Mao, Xue Bai, Xiaoting Wei, Bingning Wang, Jiangtao Li, Yang Xu, Ting Liu, Shuang Chang, Yang W Shao, Jun Guo, Jianming Ying, Lu Si
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications. Cancer research communications (2024)
Jie Dai, Jia Jia, Fanshuang Zhang, Kaihua Liu, Yanfeng Xi, Pei Yuan, Lili Mao, Xue Bai, Xiaoting Wei, Bingning Wang, Jiangtao Li, Yang Xu, Ting Liu, Shuang Chang, Yang W Shao, Jun Guo, Jianming Ying, Lu Si
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications. Cancer research communications (2024)
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu, Jun Guo
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study. BMC cancer 23 (1) (2023)
Jing Shi, Tao Jiao, Qian Guo, Weining Weng, Linjie Ma, Qing Zhang, Lijun Wang, Jianjian Zhang, Caiwei Chen, Yaling Huang, Mingqiao Wang, Rong Pan, Yanfang Tang, Wen-Hao Hu, Tao Meng, Shu-Hui Liu, Jun Guo, Yan Kong, Xun Meng
A cell surface-binding antibody atlas nominates a MUC18-directed antibody-drug conjugate for targeting melanoma. Cancer research (2023)
Xinan Sheng, Lin Wang, Zhisong He, Yanxia Shi, Hong Luo, Weiqing Han, Xin Yao, Benkang Shi, Zhenhua Liu, Changlu Hu, Ziling Liu, Hong-Qian Guo, Guohua Yu, Zhigang Ji, Jian-Ming Ying, Yun Ling, Shiying Yu, Yi Hu, Jianming Guo, Jianmin Fang, Aiping Zhou, Jun Guo
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu, Jun Guo
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study. BMC cancer 23 (1) (2023)
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu, Jun Guo
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study. BMC cancer 23 (1) (2023)
Lili Mao, Meiyu Fang, Yu Chen, Xiaoting Wei, Jun Cao, Jing Lin, Peng Zhang, Ling Chen, Xiao Cao, Yujun Chen, Jun Guo, Lu Si
Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Xieqiao Yan, Xinan Sheng, Zhihong Chi, Lu Si, Chuanliang Cui, Yan Kong, Bixia Tang, Lili Mao, Xuan Wang, Bin Lian, Siming Li, Xue Bai, Li Zhou, Jie Dai, Hong Yao, Jun Guo
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2021)
Chuanliang Cui, Canqiang Xu, Wenxian Yang, Zhihong Chi, Xinan Sheng, Lu Si, Yihong Xie, Jinyu Yu, Shun Wang, Rongshan Yu, Jun Guo, Yan Kong
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma. NPJ genomic medicine 6 (1) (2021)
Bixia Tang, Xieqiao Yan, Xinan Sheng, Lu Si, Chuanliang Cui, Yan Kong, Lili Mao, Bin Lian, Xue Bai, Xuan Wang, Siming Li, Li Zhou, Jiayi Yu, Jie Dai, Kai Wang, Jinwei Hu, Lihou Dong, Haifeng Song, Hai Wu, Hui Feng, Sheng Yao, Zhihong Chi, Jun Guo
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients. Journal of hematology & oncology 12 (1) (2019)